Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Intrawound Vancomycin in Adolescent Idiopathic Scoliosis Surgery
jRCTs061250011Active, not recruiting
- Start
- Jun 2025
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vancomycin in adolescent idiopathic scoliosis (AIS). Primary endpoint: Postoperative renal dysfunction. Started Jun 2025; status: active, not recruiting.
02
Drugs
vancomycin
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on jRCTs061250011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061250011.